 | • レポートコード：QYR9ST02970 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の非侵襲性癌診断市場について調査・分析し、以下の構成でお届け致します。非侵襲性癌診断の種類別には、CTC、CTNAS、エキソソームに、用途別には、血液、尿、唾液に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別非侵襲性癌診断売上データ ・地域別非侵襲性癌診断市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別非侵襲性癌診断市場規模：CTC、CTNAS、エキソソーム ・用途別非侵襲性癌診断市場規模：血液、尿、唾液 ・主要メーカーの企業情報：Gen-Probe Inc、Digene Corporation、Quest Diagnostics Inc、Cancer, Genetics Inc、BIOVIEW Inc、AVIVA Biosciences Corporation、Laboratory Corporation of America Holdings (LabCorp)、A&G Pharmaceutical、Affymetrix Inc、Precision Therapeutics ・非侵襲性癌診断の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Global non invasive cancer diagnostics and technologies market is anticipated to show lucrative growth over the forecast period owing to factor such as rising demand for minimally invasive therapeutics and diagnosis for the treatment of cancer. Moreover, increasing prevalence of cancer because of rising aging population and unhealthy lifestyle is also important factor that is fueling the growth of this market. Commercialization of non invasive cancer diagnostics and technologies is expected to grow owing to completion of human genome project (HGP) which will help in identifying chemical base pairs which make up DNA, hence opening avenues for market players. Rising awareness amongst people about the advantages of early diagnosis and treatment of cancer has led to a hike in number of people undergoing diagnosis. Furthermore, growing research and development in cancer diagnosis and treatment is another factor that is boosting the growth. Advancements in cancer detection technologies like cancer biomarkers and fluorescence in situ hybridization (FISH) technique are also expected to contribute towards the growth of this market.
The global non invasive cancer diagnostics and technologies market is segmented into type and technology. Based on type this market is further sub segmented into breast cancer, blood cancer, lung cancer and solid tumors. Breast cancer held the largest share in 2014 owing to factor such as increasing incidence of breast cancer. Moreover, rising awareness amongst people about symptoms, diagnosis and therapies about breast cancer has contributed towards the dominance of this segment. Also, government and non-government organization’s (NGO) initiatives to create awareness about breast cancer early diagnosis and treatment are also helping to grow this market. Breast cancer segment is also expected to witness lucrative growth over the coming seven years as a consequence of advancements like lumpectomy and partial mastectomy. Based on technology the market is segmented into immunochemistry, molecular diagnosis and clinical chemistry. Molecular diagnostic market held the largest share in 2014 as a consequence of various advantages associated to it. These advantages include high precision of diagnosis such as high specificity, high sensitivity, and rapid turnaround time.
The global Non-Invasive Cancer Diagnostics market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Non-Invasive Cancer Diagnostics market based on company, product type, end user and key regions.
This report studies the global market size of Non-Invasive Cancer Diagnostics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Non-Invasive Cancer Diagnostics in these regions.
This research report categorizes the global Non-Invasive Cancer Diagnostics market by top players/brands, region, type and end user. This report also studies the global Non-Invasive Cancer Diagnostics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Gen-Probe Inc
Digene Corporation
Quest Diagnostics Inc
Cancer, Genetics Inc
BIOVIEW Inc
AVIVA Biosciences Corporation
Laboratory Corporation of America Holdings (LabCorp)
A&G Pharmaceutical
Affymetrix Inc
Precision Therapeutics
Market size by Product
CTCs
CTNAS
Exosomes
Market size by End User
Blood
Urine
Saliva
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Non-Invasive Cancer Diagnostics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Non-Invasive Cancer Diagnostics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Non-Invasive Cancer Diagnostics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Non-Invasive Cancer Diagnostics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Non-Invasive Cancer Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Non-Invasive Cancer Diagnostics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Non-Invasive Cancer Diagnostics Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by Product
1.4.2 CTCs
1.4.3 CTNAS
1.4.4 Exosomes
1.5 Market by End User
1.5.1 Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by End User
1.5.2 Blood
1.5.3 Urine
1.5.4 Saliva
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Non-Invasive Cancer Diagnostics Market Size
2.1.1 Global Non-Invasive Cancer Diagnostics Revenue 2014-2025
2.1.2 Global Non-Invasive Cancer Diagnostics Sales 2014-2025
2.2 Non-Invasive Cancer Diagnostics Growth Rate by Regions
2.2.1 Global Non-Invasive Cancer Diagnostics Sales by Regions
2.2.2 Global Non-Invasive Cancer Diagnostics Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Non-Invasive Cancer Diagnostics Sales by Manufacturers
3.1.1 Non-Invasive Cancer Diagnostics Sales by Manufacturers
3.1.2 Non-Invasive Cancer Diagnostics Sales Market Share by Manufacturers
3.1.3 Global Non-Invasive Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2 Non-Invasive Cancer Diagnostics Revenue by Manufacturers
3.2.1 Non-Invasive Cancer Diagnostics Revenue by Manufacturers (2014-2019)
3.2.2 Non-Invasive Cancer Diagnostics Revenue Share by Manufacturers (2014-2019)
3.3 Non-Invasive Cancer Diagnostics Price by Manufacturers
3.4 Non-Invasive Cancer Diagnostics Manufacturing Base Distribution, Product Types
3.4.1 Non-Invasive Cancer Diagnostics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Non-Invasive Cancer Diagnostics Product Type
3.4.3 Date of International Manufacturers Enter into Non-Invasive Cancer Diagnostics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Non-Invasive Cancer Diagnostics Sales by Product
4.2 Global Non-Invasive Cancer Diagnostics Revenue by Product
4.3 Non-Invasive Cancer Diagnostics Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Non-Invasive Cancer Diagnostics Breakdown Data by End User
6 North America
6.1 North America Non-Invasive Cancer Diagnostics by Countries
6.1.1 North America Non-Invasive Cancer Diagnostics Sales by Countries
6.1.2 North America Non-Invasive Cancer Diagnostics Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Non-Invasive Cancer Diagnostics by Product
6.3 North America Non-Invasive Cancer Diagnostics by End User
7 Europe
7.1 Europe Non-Invasive Cancer Diagnostics by Countries
7.1.1 Europe Non-Invasive Cancer Diagnostics Sales by Countries
7.1.2 Europe Non-Invasive Cancer Diagnostics Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Non-Invasive Cancer Diagnostics by Product
7.3 Europe Non-Invasive Cancer Diagnostics by End User
8 Asia Pacific
8.1 Asia Pacific Non-Invasive Cancer Diagnostics by Countries
8.1.1 Asia Pacific Non-Invasive Cancer Diagnostics Sales by Countries
8.1.2 Asia Pacific Non-Invasive Cancer Diagnostics Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Non-Invasive Cancer Diagnostics by Product
8.3 Asia Pacific Non-Invasive Cancer Diagnostics by End User
9 Central & South America
9.1 Central & South America Non-Invasive Cancer Diagnostics by Countries
9.1.1 Central & South America Non-Invasive Cancer Diagnostics Sales by Countries
9.1.2 Central & South America Non-Invasive Cancer Diagnostics Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Non-Invasive Cancer Diagnostics by Product
9.3 Central & South America Non-Invasive Cancer Diagnostics by End User
10 Middle East and Africa
10.1 Middle East and Africa Non-Invasive Cancer Diagnostics by Countries
10.1.1 Middle East and Africa Non-Invasive Cancer Diagnostics Sales by Countries
10.1.2 Middle East and Africa Non-Invasive Cancer Diagnostics Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Non-Invasive Cancer Diagnostics by Product
10.3 Middle East and Africa Non-Invasive Cancer Diagnostics by End User
11 Company Profiles
11.1 Gen-Probe Inc
11.1.1 Gen-Probe Inc Company Details
11.1.2 Company Business Overview
11.1.3 Gen-Probe Inc Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Gen-Probe Inc Non-Invasive Cancer Diagnostics Products Offered
11.1.5 Gen-Probe Inc Recent Development
11.2 Digene Corporation
11.2.1 Digene Corporation Company Details
11.2.2 Company Business Overview
11.2.3 Digene Corporation Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Digene Corporation Non-Invasive Cancer Diagnostics Products Offered
11.2.5 Digene Corporation Recent Development
11.3 Quest Diagnostics Inc
11.3.1 Quest Diagnostics Inc Company Details
11.3.2 Company Business Overview
11.3.3 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Products Offered
11.3.5 Quest Diagnostics Inc Recent Development
11.4 Cancer, Genetics Inc
11.4.1 Cancer, Genetics Inc Company Details
11.4.2 Company Business Overview
11.4.3 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Products Offered
11.4.5 Cancer, Genetics Inc Recent Development
11.5 BIOVIEW Inc
11.5.1 BIOVIEW Inc Company Details
11.5.2 Company Business Overview
11.5.3 BIOVIEW Inc Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2014-2019)
11.5.4 BIOVIEW Inc Non-Invasive Cancer Diagnostics Products Offered
11.5.5 BIOVIEW Inc Recent Development
11.6 AVIVA Biosciences Corporation
11.6.1 AVIVA Biosciences Corporation Company Details
11.6.2 Company Business Overview
11.6.3 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2014-2019)
11.6.4 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Products Offered
11.6.5 AVIVA Biosciences Corporation Recent Development
11.7 Laboratory Corporation of America Holdings (LabCorp)
11.7.1 Laboratory Corporation of America Holdings (LabCorp) Company Details
11.7.2 Company Business Overview
11.7.3 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Products Offered
11.7.5 Laboratory Corporation of America Holdings (LabCorp) Recent Development
11.8 A&G Pharmaceutical
11.8.1 A&G Pharmaceutical Company Details
11.8.2 Company Business Overview
11.8.3 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2014-2019)
11.8.4 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Products Offered
11.8.5 A&G Pharmaceutical Recent Development
11.9 Affymetrix Inc
11.9.1 Affymetrix Inc Company Details
11.9.2 Company Business Overview
11.9.3 Affymetrix Inc Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Affymetrix Inc Non-Invasive Cancer Diagnostics Products Offered
11.9.5 Affymetrix Inc Recent Development
11.10 Precision Therapeutics
11.10.1 Precision Therapeutics Company Details
11.10.2 Company Business Overview
11.10.3 Precision Therapeutics Non-Invasive Cancer Diagnostics Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Precision Therapeutics Non-Invasive Cancer Diagnostics Products Offered
11.10.5 Precision Therapeutics Recent Development
12 Future Forecast
12.1 Non-Invasive Cancer Diagnostics Market Forecast by Regions
12.1.1 Global Non-Invasive Cancer Diagnostics Sales Forecast by Regions 2019-2025
12.1.2 Global Non-Invasive Cancer Diagnostics Revenue Forecast by Regions 2019-2025
12.2 Non-Invasive Cancer Diagnostics Market Forecast by Product
12.2.1 Global Non-Invasive Cancer Diagnostics Sales Forecast by Product 2019-2025
12.2.2 Global Non-Invasive Cancer Diagnostics Revenue Forecast by Product 2019-2025
12.3 Non-Invasive Cancer Diagnostics Market Forecast by End User
12.4 North America Non-Invasive Cancer Diagnostics Forecast
12.5 Europe Non-Invasive Cancer Diagnostics Forecast
12.6 Asia Pacific Non-Invasive Cancer Diagnostics Forecast
12.7 Central & South America Non-Invasive Cancer Diagnostics Forecast
12.8 Middle East and Africa Non-Invasive Cancer Diagnostics Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Non-Invasive Cancer Diagnostics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Non-Invasive Cancer Diagnostics Product Picture
Table Non-Invasive Cancer Diagnostics Market Segments
Table Key Manufacturers Non-Invasive Cancer Diagnostics Covered
Table Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Non-Invasive Cancer Diagnostics Sales Market Share by Product 2014-2025
Figure CTCs Product Picture
Table Major Manufacturers of CTCs
Figure CTNAS Product Picture
Table Major Manufacturers of CTNAS
Figure Exosomes Product Picture
Table Major Manufacturers of Exosomes
Table Global Non-Invasive Cancer Diagnostics Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Blood
Figure Urine
Figure Saliva
Figure Non-Invasive Cancer Diagnostics Report Years Considered
Figure Global Non-Invasive Cancer Diagnostics Market Size 2014-2025 (Million US$)
Figure Global Non-Invasive Cancer Diagnostics Sales 2014-2025 (K Units)
Table Global Non-Invasive Cancer Diagnostics Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Non-Invasive Cancer Diagnostics Sales by Regions 2014-2019 (K Units)
Table Global Non-Invasive Cancer Diagnostics Sales Market Share by Regions 2014-2019
Figure Global Non-Invasive Cancer Diagnostics Sales Market Share by Regions 2014-2019
Figure 2018 Global Non-Invasive Cancer Diagnostics Sales Market Share by Regions
Table Global Non-Invasive Cancer Diagnostics Revenue by Regions 2014-2019 (Million US$)
Table Global Non-Invasive Cancer Diagnostics Revenue Market Share by Regions 2014-2019
Figure Global Non-Invasive Cancer Diagnostics Revenue Market Share by Regions 2014-2019
Figure 2018 Global Non-Invasive Cancer Diagnostics Revenue Market Share by Regions
Table Global Non-Invasive Cancer Diagnostics Sales by Manufacturers (2014-2019) (K Units)
Table Global Non-Invasive Cancer Diagnostics Sales Share by Manufacturers (2014-2019)
Figure Global Non-Invasive Cancer Diagnostics Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Non-Invasive Cancer Diagnostics Revenue by Manufacturers (2014-2019) (Million USD)
Table Non-Invasive Cancer Diagnostics Revenue Share by Manufacturers (2014-2019)
Figure Non-Invasive Cancer Diagnostics Value Share by Manufacturers in 2018
Table Key Manufacturers Non-Invasive Cancer Diagnostics Price (2014-2019) (USD/Unit)
Table Non-Invasive Cancer Diagnostics Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Non-Invasive Cancer Diagnostics Product Type
Table Date of International Manufacturers Enter into Non-Invasive Cancer Diagnostics Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Non-Invasive Cancer Diagnostics Sales by Product (2014-2019) (K Units)
Table Global Non-Invasive Cancer Diagnostics Sales Share by Product (2014-2019)
Figure Global Non-Invasive Cancer Diagnostics Sales Market Share by Product (2014-2019)
Figure Global Non-Invasive Cancer Diagnostics Sales Market Share by Product in 2018
Table Global Non-Invasive Cancer Diagnostics Revenue by Product (2014-2019) (Million US$)
Table Global Non-Invasive Cancer Diagnostics Revenue Share by Product (2014-2019)
Figure Global Non-Invasive Cancer Diagnostics Revenue Market Share by Product (2014-2019)
Figure Global Non-Invasive Cancer Diagnostics Revenue Market Share by Product in 2018
Table Non-Invasive Cancer Diagnostics Price by Product 2014-2019 (USD/Unit)
Table Global Non-Invasive Cancer Diagnostics Sales by End User (2014-2019) (K Units)
Table Global Non-Invasive Cancer Diagnostics Sales Share by End User (2014-2019)
Figure Global Sales Non-Invasive Cancer Diagnostics Market Share by End User (2014-2019)
Figure Global Sales Non-Invasive Cancer Diagnostics Market Share by End User in 2018
Figure North America Non-Invasive Cancer Diagnostics Sales Growth Rate 2014-2019 (K Units)
Figure North America Non-Invasive Cancer Diagnostics Revenue Growth Rate 2014-2019 (Million US$)
Table North America Non-Invasive Cancer Diagnostics Sales by Countries (2014-2019) (K Units)
Table North America Non-Invasive Cancer Diagnostics Sales Market Share by Countries (2014-2019)
Figure 2018 North America Non-Invasive Cancer Diagnostics Sales Market Share by Countries
Table North America Non-Invasive Cancer Diagnostics Revenue by Countries (2014-2019) (Million US$)
Table North America Non-Invasive Cancer Diagnostics Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Non-Invasive Cancer Diagnostics Revenue Market Share by Countries
Figure United States Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure United States Non-Invasive Cancer Diagnostics Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Canada Non-Invasive Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Non-Invasive Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Table North America Non-Invasive Cancer Diagnostics Sales by Product (2014-2019) (K Units)
Table North America Non-Invasive Cancer Diagnostics Sales Market Share by Product (2014-2019)
Figure 2018 North America Non-Invasive Cancer Diagnostics Market Share by Product
Table North America Non-Invasive Cancer Diagnostics Sales by End User (2014-2019) (K Units)
Table North America Non-Invasive Cancer Diagnostics Sales Market Share by End User (2014-2019)
Figure 2018 North America Non-Invasive Cancer Diagnostics Market Share by End User
Figure Europe Non-Invasive Cancer Diagnostics Sales Growth Rate 2014-2019 (K Units)
Figure Europe Non-Invasive Cancer Diagnostics Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Non-Invasive Cancer Diagnostics Sales by Countries (2014-2019) (K Units)
Table Europe Non-Invasive Cancer Diagnostics Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Non-Invasive Cancer Diagnostics Sales Market Share by Countries
Table Europe Non-Invasive Cancer Diagnostics Revenue by Countries (2014-2019) (Million US$)
Table Europe Non-Invasive Cancer Diagnostics Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Non-Invasive Cancer Diagnostics Revenue Market Share by Countries
Figure Germany Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Germany Non-Invasive Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure France Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure France Non-Invasive Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure UK Non-Invasive Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Italy Non-Invasive Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Russia Non-Invasive Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Non-Invasive Cancer Diagnostics Sales by Product (2014-2019) (K Units)
Table Europe Non-Invasive Cancer Diagnostics Sales Market Share by Product (2014-2019)
Figure 2018 Europe Non-Invasive Cancer Diagnostics Market Share by Product
Table Europe Non-Invasive Cancer Diagnostics Sales by End User (2014-2019) (K Units)
Table Europe Non-Invasive Cancer Diagnostics Sales Market Share by End User (2014-2019)
Figure 2018 Europe Non-Invasive Cancer Diagnostics Market Share by End User
Figure Asia Pacific Non-Invasive Cancer Diagnostics Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Non-Invasive Cancer Diagnostics Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Non-Invasive Cancer Diagnostics Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Non-Invasive Cancer Diagnostics Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Non-Invasive Cancer Diagnostics Sales Market Share by Countries
Table Asia Pacific Non-Invasive Cancer Diagnostics Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Non-Invasive Cancer Diagnostics Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Non-Invasive Cancer Diagnostics Revenue Market Share by Countries
Figure China Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure China Non-Invasive Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Japan Non-Invasive Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Korea Non-Invasive Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure India Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure India Non-Invasive Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Australia Non-Invasive Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Non-Invasive Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Non-Invasive Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Non-Invasive Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Non-Invasive Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Non-Invasive Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Non-Invasive Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Non-Invasive Cancer Diagnostics Sales by Product (2014-2019) (K Units)
Table Asia Pacific Non-Invasive Cancer Diagnostics Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Non-Invasive Cancer Diagnostics Market Share by Product
Table Asia Pacific Non-Invasive Cancer Diagnostics Sales by End User (2014-2019) (K Units)
Table Asia Pacific Non-Invasive Cancer Diagnostics Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Non-Invasive Cancer Diagnostics Market Share by End User
Figure Central & South America Non-Invasive Cancer Diagnostics Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Non-Invasive Cancer Diagnostics Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Non-Invasive Cancer Diagnostics Sales by Countries (2014-2019) (K Units)
Table Central & South America Non-Invasive Cancer Diagnostics Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Non-Invasive Cancer Diagnostics Sales Market Share by Countries
Table Central & South America Non-Invasive Cancer Diagnostics Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Non-Invasive Cancer Diagnostics Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Non-Invasive Cancer Diagnostics Revenue Market Share by Countries
Figure Brazil Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Non-Invasive Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Non-Invasive Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Non-Invasive Cancer Diagnostics Sales by Product (2014-2019) (K Units)
Table Central & South America Non-Invasive Cancer Diagnostics Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Non-Invasive Cancer Diagnostics Market Share by Product
Table Central & South America Non-Invasive Cancer Diagnostics Sales by End User (2014-2019) (K Units)
Table Central & South America Non-Invasive Cancer Diagnostics Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Non-Invasive Cancer Diagnostics Market Share by End User
Figure Middle East and Africa Non-Invasive Cancer Diagnostics Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Non-Invasive Cancer Diagnostics Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Non-Invasive Cancer Diagnostics Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Non-Invasive Cancer Diagnostics Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Non-Invasive Cancer Diagnostics Sales Market Share by Countries
Table Middle East and Africa Non-Invasive Cancer Diagnostics Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Non-Invasive Cancer Diagnostics Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Non-Invasive Cancer Diagnostics Revenue Market Share by Countries
Figure GCC Countries Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Non-Invasive Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Non-Invasive Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Non-Invasive Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Non-Invasive Cancer Diagnostics Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Non-Invasive Cancer Diagnostics Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Non-Invasive Cancer Diagnostics Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Non-Invasive Cancer Diagnostics Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Non-Invasive Cancer Diagnostics Market Share by Product
Table Middle East and Africa Non-Invasive Cancer Diagnostics Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Non-Invasive Cancer Diagnostics Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Non-Invasive Cancer Diagnostics Market Share by End User
Table Gen-Probe Inc Company Details
Table Gen-Probe Inc Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Gen-Probe Inc Recent Development
Table Digene Corporation Company Details
Table Digene Corporation Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Digene Corporation Recent Development
Table Quest Diagnostics Inc Company Details
Table Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Quest Diagnostics Inc Recent Development
Table Cancer, Genetics Inc Company Details
Table Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Cancer, Genetics Inc Recent Development
Table BIOVIEW Inc Company Details
Table BIOVIEW Inc Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table BIOVIEW Inc Recent Development
Table AVIVA Biosciences Corporation Company Details
Table AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AVIVA Biosciences Corporation Recent Development
Table Laboratory Corporation of America Holdings (LabCorp) Company Details
Table Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Laboratory Corporation of America Holdings (LabCorp) Recent Development
Table A&G Pharmaceutical Company Details
Table A&G Pharmaceutical Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table A&G Pharmaceutical Recent Development
Table Affymetrix Inc Company Details
Table Affymetrix Inc Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Affymetrix Inc Recent Development
Table Precision Therapeutics Company Details
Table Precision Therapeutics Non-Invasive Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Precision Therapeutics Recent Development
Table Global Non-Invasive Cancer Diagnostics Sales Forecast by Regions 2019-2025 (K Units)
Table Global Non-Invasive Cancer Diagnostics Sales Market Share Forecast by Regions 2019-2025
Table Global Non-Invasive Cancer Diagnostics Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Non-Invasive Cancer Diagnostics Revenue Market Share Forecast by Regions 2019-2025
Table Global Non-Invasive Cancer Diagnostics Sales Forecast by Product 2019-2025 (K Units)
Table Global Non-Invasive Cancer Diagnostics Sales Market Share Forecast by Product 2019-2025
Table Global Non-Invasive Cancer Diagnostics Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Non-Invasive Cancer Diagnostics Revenue Market Share Forecast by Product 2019-2025
Table Global Non-Invasive Cancer Diagnostics Sales Forecast by End User 2019-2025 (K Units)
Table Global Non-Invasive Cancer Diagnostics Sales Market Share Forecast by End User 2019-2025
Figure North America Non-Invasive Cancer Diagnostics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Non-Invasive Cancer Diagnostics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Non-Invasive Cancer Diagnostics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Non-Invasive Cancer Diagnostics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Non-Invasive Cancer Diagnostics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Non-Invasive Cancer Diagnostics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Non-Invasive Cancer Diagnostics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Non-Invasive Cancer Diagnostics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Non-Invasive Cancer Diagnostics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Non-Invasive Cancer Diagnostics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Non-Invasive Cancer Diagnostics Value Chain
Table Non-Invasive Cancer Diagnostics Customers List
Table Non-Invasive Cancer Diagnostics Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
がん診断の世界市場：インサイト・予測 This report manily covers cancer diagnostics market.Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body.North America is expected to account for the largest share in the cancer diagnostics market, followed by Europe and Asia.…- 頭頸部癌診断の世界市場：市場規模・現状・予測 Head and neck cancer begins in squamous cells that line the mucosal surfaces of the head and neck such as, inside the mouth, the nose, and the throat. The head and neck cancers include specific areas of the body such as oral cavity, pharynx, larynx, paranasal sinuses and nasal cavity, and salivary g…
- 子宮頸がん用治療及び診断の世界市場：市場規模・現状・予測 Therapies and Diagnostics for Cervical Cancer refers to a series of methods and medical devices that can be used for the diagnosis and treatment of cervical cancer.The factors that are driving the cervical cancer market are HPV infection, women having many sexual partners, women getting sexually act…
- 子宮頸がん用治療及び診断の世界市場：市場規模・現状・予測 Therapies and Diagnostics for Cervical Cancer refers to a series of methods and medical devices that can be used for the diagnosis and treatment of cervical cancer.The factors that are driving the cervical cancer market are HPV infection, women having many sexual partners, women getting sexually act…
- 肺癌液体生検の世界市場：市場規模・現状・予測 Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer.CtDNA and CTCs have been the most explored technologies for commercial applications up to the present time. In 2018, the global Lung Ca…